Drug combination of beta 2 agonist and a progestin for the treatment of muscle loss

Details for Australian Patent Application No. 2008240379 (hide)

Owner Acacia Pharma Limited

Inventors Gilbert, Julian Clive; Gristwood, Robert William

Agent Madderns

Pub. Number AU-B-2008240379

PCT Pub. Number WO2008/129308

Priority 0707931.2 24.04.07 GB; 0710101.7 25.05.07 GB; 0707930.4 24.04.07 GB

Filing date 24 April 2008

Wipo publication date 30 October 2008

Acceptance publication date 4 October 2012

International Classifications

A61K 45/06 Medicinal preparations containing active ingredients not provided for in groups

A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/167 - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/57 - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 31/704

A61P 9/00 Drugs for disorders of the cardiovascular system

A61P 11/00 Drugs for disorders of the respiratory system

A61P 31/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 Antineoplastic agents

A61P 43/00 Drugs for specific purposes, not provided for in groups

Event Publications

3 December 2009 PCT application entered the National Phase

  PCT publication WO2008/129308 Priority application(s): WO2008/129308

4 October 2012 Application Accepted

  Published as AU-B-2008240379

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008240382-Underwater structures

2008240374-Sustained release